Studies show that clinical trials conducted in the United States tend to involve primarily middle and upper-class, younger, white male participants. Ideally of course, a clinical trial’s population would consist of a variety of different sexes, race and ethnicities.
Read nowFigures from 2014 showed that up to 89% of pharmaceutical companies were failing to notice the potential of non-traditional methods of recruitment.[2] While this is no doubt changing, many companies have plenty of room to improve.
Read nowVirtual reality (VR) has captivated the world of healthcare communications, creating enormous opportunity for pharmaceutical companies to bring their concepts to life. From mechanisms of action to disease awareness, the healthcare industry has been quick to adopt VR – but the opportunities are far from over.
Read nowA very common pest in most of our homes, the fruit fly (Drosophila melanogaster), is one of the most important model organisms in scientific research. To date, no less than nine Nobel prizes have been awarded for research based on the fruit fly.
Read nowIf you look down at what you’re wearing and observe the material it’s made out of, pick up your phone and browse social media, or peer into your medicine cabinet, it is clear that microscopes have greatly shaped our understanding of the world we live in and the way we live it – often in ways that we don’t realise.
Read nowAs everyone is well aware, social media can be a useful tool for business to access target audiences. The same is true in the healthcare environment, where pharmaceutical companies want to reach healthcare professionals to communicate the value proposition of the treatments they produce and market.
Read nowThe General Data Protection Regulation (GDPR) has had many companies focused on data storage, processing and compliance over the last 12-24 months - and rightly so. As of last week, we have seen that the GDPR has teeth and that regulators intend to enforce the rules.
Read nowFollowing today's defeat of the Prime Minister's Brexit deal, many thousands of people up and down the UK will be extremely worried. Not because of the economic or political implications, but because their wellbeing and potentially even their life is dependent on a consistent supply of medicine.
Read nowTalking about science and selling scientific products and services to varied audiences is often not so different from traditional marketing.
Read nowThat’s a great question, and as science communication specialists, it’s a question that we ask ourselves a lot. To answer that question let’s begin with a boat full of sailors in 1747.
Read now